Complications of Devices, Implants, and Grafts — Clinical Documentation Guide (2026)

🔍 Definition

Complications of devices, implants, and grafts are adverse conditions that arise as a direct consequence of an internal prosthetic device, implant, or graft that was surgically placed or implanted. Under ICD-10-CM Official Guidelines Section I.C.19.g, these complications are classified in categories T82–T85 and encompass mechanical failures (breakage, displacement, leakage, obstruction, perforation), infections and inflammatory reactions, hemorrhage, fibrosis, pain, stenosis, thrombosis, and other device-related adverse effects.

Critically, these conditions are distinguished from:

• Complications of surgical/medical care (T80–T81, T88) — intraoperative complications, postprocedural hematomas, wound dehiscence
• Normal healing — expected postoperative recovery without a specific complication
• Complications of external prosthetic devices — classified elsewhere (e.g., fitting/adjustment of prosthetic limb)

The four major anatomic/functional groupings are: (1) T82 — cardiac and vascular prosthetic devices; (2) T83 — genitourinary prosthetic devices; (3) T84 — orthopedic prosthetic devices and implants; and (4) T85 — other internal prosthetic devices (neurological, ocular, breast, peritoneal, gastrointestinal). Seventh-character extension is required on all applicable codes: A = initial encounter, D = subsequent encounter, S = sequela. See CDC/NCHS ICD-10-CM tabular instructions.

🗂️ Alternative Terminology

🩺 Signs & Symptoms

Clinical presentation varies widely by device type and complication category. Coders and CDI specialists should watch for these documented findings that signal a reportable complication:

Mechanical Complications

• Device dislocation, migration, or displacement (e.g., hip prosthesis dislocation, pacing lead migration)
• Device malposition, obstruction, or leakage (e.g., VP shunt obstruction, peritoneal catheter malfunction)
• Loosening, breakage, or perforation (e.g., aseptic loosening of hip/knee prosthesis)
• Reoperation or revision surgery prompted by device failure
• Abnormal imaging findings: radiolucent lines around prosthesis (loosening), discontinuity of hardware

Infectious Complications

• Fever, leukocytosis, elevated CRP/ESR, positive cultures (wound, blood, aspirate)
• Local warmth, erythema, swelling, drainage at or near device site
• Positive joint aspirate — elevated WBC count (>1,100/μL synovial WBC for PJI per AAOS PJI guidelines)
• MRSA/MSSA bacteremia with documented device as source
• Sinus tract communicating with prosthesis (pathognomonic of PJI)
• Pocket erosion or wound breakdown at pacemaker/ICD pocket site

Other Systemic/Local Complications

• Hemorrhage: unexpected bleeding at or around device site (T82.81x, T83.81x, T84.81x, T85.81x)
• Fibrosis: capsular contracture (breast implant), pericardial fibrosis (pacemaker), progressive hardening
• Pain: unexplained pain at prosthesis site, pain out of proportion to expected recovery
• Stenosis: decreasing graft flow, re-stenosis on imaging (T82.85x, T83.85x, T84.85x, T85.85x)
• Thrombosis: acute DVT from vascular graft, valve thrombosis causing hemodynamic instability (T82.86x, T85.86x)

🧭 Differential Diagnosis

📋 Clinical Indicators for Coders/CDI

🦴 Anatomy & Pathophysiology

Understanding the anatomic relationships for each device class informs correct code assignment:

Cardiac and Vascular Prosthetic Devices (T82)

Prosthetic heart valves (mechanical or bioprosthetic) are implanted to replace native valves affected by stenosis or regurgitation. Mechanical complications include leaflet obstruction (often due to pannus ingrowth or thrombus), structural valve deterioration (SVD) in bioprostheses, and paravalvular leak. Cardiac electronic devices (pacemakers, ICDs, CRT devices) consist of a pulse generator and intracardiac leads. Lead dislodgement occurs most commonly in the first 4–6 weeks post-implantation. CABG grafts (saphenous vein, internal mammary artery) are susceptible to early thrombosis and late atherosclerotic disease. Vascular grafts (aortic, peripheral, dialysis access) may develop stenosis, thrombosis, infection, or anastomotic pseudoaneurysm. According to American Heart Association device guidance, infection involving the intracardiac lead or generator pocket (CIED infection) carries a 1-year mortality of up to 35%.

Genitourinary Prosthetic Devices (T83)

Urinary catheters (indwelling Foley, suprapubic), nephrostomy tubes, ureteral stents, urethral stents, and IUDs are included. Catheter-associated UTI (CAUTI) — when the catheter is documented as the source — maps to T83.511A (infection of indwelling urethral catheter) + organism code. IUD complications include displacement, expulsion, and perforation of uterine wall.

Orthopedic Prosthetic Devices and Implants (T84)

Total joint arthroplasty (hip, knee, shoulder, elbow, ankle) involves replacing articular surfaces with metal (cobalt-chromium, titanium) and polyethylene components. Aseptic loosening results from wear debris causing osteolysis at the bone-implant interface. Periprosthetic joint infection (PJI) occurs via hematogenous seeding or direct inoculation at surgery; biofilm formation on metal surfaces makes eradication extremely difficult. The AAOS PJI clinical practice guidelines define early PJI (<3 months), delayed PJI (3–12 months), and late/hematogenous PJI (>12 months). Internal fixation devices (screws, plates, rods, intramedullary nails) can break or loosen, and periprosthetic fractures around femoral stems represent a growing orthopedic complication.

Other Internal Prosthetic Devices (T85)

Ventricular shunts (ventriculoperitoneal, ventriculoatrial) drain excess CSF in hydrocephalus; malfunction may be proximal (ventricular catheter obstruction by choroid plexus) or distal (peritoneal catheter obstruction). Neurostimulators include spinal cord stimulators (SCS), peripheral nerve stimulators, and deep brain stimulators (DBS); complications include lead migration, generator failure, and infection. Breast implants (saline or silicone) may rupture (intracapsular vs. extracapsular), develop capsular contracture (Baker grades I–IV), or become infected. Peritoneal dialysis catheters are at risk for peritonitis (T85.61xA + organism), the leading cause of catheter loss and technique failure.

💊 Medication Impact / Treatment

Medications directly influence both the development and management of device complications:

Anticoagulants and Antiplatelet Agents

Patients with prosthetic heart valves require life-long anticoagulation (warfarin with target INR 2.5–3.5 for mechanical valves per 2021 AHA/ACC Valve Guidelines). Sub-therapeutic INR increases thrombosis risk (T82.867x); supratherapeutic INR increases hemorrhage risk (T82.817x). Document anticoagulation status, INR, and any medication adjustments.

Antibiotics — Device Infection Treatment

Suppressive antibiotic therapy (chronic oral suppression) for PJI or CIED infection not amenable to explantation. MRSA infections require vancomycin (J3370) or daptomycin (J0878); MSSA may use oxacillin/nafcillin or cefazolin. Antibiotic-impregnated cement spacers (containing tobramycin or vancomycin) are used in two-stage hip/knee exchange for PJI — the local antibiotic delivery is captured by HCPCS L codes. Document specific organisms and sensitivities to support J-code selection.

Immunosuppressants

Transplant recipients, patients on biologic agents (TNF inhibitors, JAK inhibitors), or chronic corticosteroid users are at markedly elevated risk for opportunistic device infections. Document immunosuppressive regimen as a comorbidity; this affects severity documentation and CC/MCC capture.

Anti-Infective Prophylaxis

Perioperative antibiotic prophylaxis (cefazolin) within 60 minutes of incision per CDC SSI prevention guidelines. Patients with joint prostheses: dental prophylaxis per 2015 ADA/AAOS statement (note: no longer universally recommended — individualized decision).

Wound/Local Treatment

Negative pressure wound therapy (NPWT/VAC) may be documented for open wound management following device removal. Captures HCPCS E2402 (NPWT pump) and A6550 (NPWT supply/dressing).

Preview ends here. The full guide continues with FY2026 ICD-10-CM code sets, CPT surgical coding, MS-DRG mapping, reimbursement guidance, CDI query templates, and an audit checklist — all available to CCO Members.

← Back to All Clinical Documentation Guides

📘 ICD-10-CM Guidelines (FY2026)

Per FY2026 ICD-10-CM Official Guidelines Section I.C.19.g — Complications of care:

General Principles

• Causation required: A code from T82–T85 is assigned only when the provider documents a cause-and-effect relationship between the device/implant/graft and the condition. Do not infer causation; query if not explicit.
• 7th character: A = initial encounter (first time patient is seen for active treatment of the complication); D = subsequent encounter (follow-up care, healing); S = sequela (late effect). Many T84–T85 codes require placeholder “x” characters before the 7th character extension.
• Sequence: The complication code (T82–T85) is typically sequenced first, followed by additional codes identifying the specific condition (e.g., organism for infection; sepsis code A41.x if sepsis is present).

Infections Due to Devices (Guideline I.C.19.g.i)

• Assign the complication code (e.g., T84.5xxA for PJI) AND an additional code from B95–B97 to identify the causative organism.
• If the documentation indicates sepsis, the sepsis code (A40.x, A41.x) is sequenced first, followed by the T-code and organism.
• Severe sepsis: add R65.20 (without septic shock) or R65.21 (with septic shock), plus codes for associated organ dysfunction.

Transplant Complications vs. Device Complications

Complications following organ transplants (heart, kidney, liver) are coded from T86.x, not from T82–T85. If a mechanical assist device (ventricular assist device — VAD) is used as a bridge to transplant, complications of the VAD itself may use T82.x codes, but post-transplant rejection uses T86.x.

POA Reporting — Hospital-Acquired Conditions (HACs)

Inpatient coders must assign POA indicators for all T-code complications. A POA indicator of N (Not present on admission) flags the condition as a potential HAC. CMS HAC category #7 specifically identifies prosthetic joint infections as hospital-acquired when POA = N. This has direct reimbursement implications — hospitals may lose the higher MS-DRG payment associated with the CC/MCC if the HAC rule applies. See CMS HAC guidance.

External Cause Codes

When applicable, assign external cause codes to identify the circumstances of device complications:

• Y83.x / Y84.x — surgical and other medical procedures as external cause of patient’s abnormal reaction, without misadventure
• Y83.1 — surgical operation with implant of artificial internal device
• Y84.8 — other medical procedures causing device complication

Status Codes — Z95, Z96, Z97

Z-status codes document the presence of a device but are NOT complication codes. They answer “the patient has this device” and are used as secondary codes when relevant to care (e.g., Z95.0 for pacemaker status, Z96.641 for right hip joint implant status). Do not assign status codes if a complication code for that device is already assigned in the same encounter — the complication code carries the full clinical meaning.

🔢 ICD-10-CM Code Set (FY2026)

T82 — Cardiac and Vascular Prosthetic Devices, Implants, and Grafts

T84 — Orthopedic Prosthetic Devices and Implants (High-Priority)

T85 — Other Internal Prosthetic Devices, Implants and Grafts

Infection Organism Codes (Code Also — Required)

Sepsis Coding with Device Infections

Z-Status Codes (Device Presence — Secondary)

🔎 Indexing

Index entries in the FY2026 ICD-10-CM Alphabetical Index:

• Complication → device, implant or graft — main entry leads to T82–T85; subterms by device type and complication nature
• Complication → cardiac device → T82.9; subterms: electronic device, pacemaker, valve prosthesis
• Complication → joint prosthesis, internal → T84.9; key subterms: dislocation (T84.02x), infection (T84.5xx), loosening, mechanical (T84.09x), periprosthetic fracture (T84.04x)
• Complication → fixation device, internal (orthopedic) → T84.9
• Complication → shunt, ventricular (communicating) → T85.01x (breakdown), T85.730A (infection)
• Infection → due to device, implant or graft → T85.79; subterms by device type
• Dislocation → prosthesis, internal → see Complication, joint prosthesis
• Loosening → joint prosthesis → T84.03x (aseptic); differentiate from T84.5xx (infectious)
• Failure → prosthesis, joint → see Complication, joint prosthesis
• Peritonitis → due to dialysis catheter → T85.691A + K65.0
• Sepsis → due to device → see Complication, infection; then sequence sepsis first per guidelines

🏥 CPT (2026)

🧾 HCPCS (2026)

📚 AHA Coding Clinic (Recent Guidance)

The following summarizes relevant AHA Coding Clinic for ICD-10-CM/PCS guidance on device complications:

• PJI coding — organism requirement (2022 Q3): When a periprosthetic joint infection is documented, an additional code from B95–B97 must be assigned to identify the causative organism. If the organism is not documented, the coder should query the provider rather than default to “unspecified.”
• Aseptic vs. septic loosening (2021 Q4): When a physician documents “joint loosening,” coders should query whether the loosening is aseptic (mechanical — T84.03x) or infectious (PJI — T84.5xx). The distinction affects DRG assignment and HCC capture significantly.
• CIED infection and lead extraction (2023 Q1): Infection involving a cardiac implantable electronic device (pacemaker/ICD) is coded to T82.7xxA. When the lead is extracted due to infection, also assign the appropriate ICD-10-PCS extraction procedure code in the inpatient setting.
• Perioperative vs. postoperative complications (2020 Q2): Complications that occur during the operative episode versus those developing post-discharge require careful 7th character assignment. A complication discovered at a return visit for symptoms uses 7th character A if it is the first active treatment encounter.
• VP shunt infection with meningitis (2019 Q4): When a ventricular shunt infection results in bacterial meningitis, code both T85.730A (infection of ventricular shunt) and the appropriate meningitis code (G00.x). The relationship is documented by the neurosurgeon.
• Breast implant illness (BIA-ALCL) (2022 Q2): Breast implant-associated anaplastic large cell lymphoma is coded to C84.7x (anaplastic large cell lymphoma) as the principal diagnosis, not as a T85 complication code. Document association with implant in medical record.

💰 HCC / Risk Adjustment (v28)

✍️ CDI Query Templates

🧑‍⚕️ Treatments (Clinical)

Periprosthetic Joint Infection (PJI)

Management of PJI depends on infection timing and organism. Per AAOS 2019 PJI CPG:

• DAIR (Debridement, Antibiotics, and Implant Retention): For acute PJI (<4 weeks from index surgery or <3 weeks of symptoms in chronic infection with stable implant) — open debridement, exchange of modular parts, retention of fixed components, followed by prolonged antibiotic therapy (typically 3–6 months for hip/knee).
• Two-stage exchange arthroplasty: Gold standard for chronic PJI — Stage 1: complete prosthesis removal + antibiotic-impregnated cement spacer (static or articulating) + 6–12 weeks IV antibiotics; Stage 2: reimplantation when infection eradicated (negative aspirate, normalized ESR/CRP). Overall success rate 85–90% for MSSA/MRSA with this approach.
• One-stage exchange: Increasingly utilized for selected patients with known susceptible organisms — full single-session removal and reimplantation with antibiotic-impregnated cement.
• Resection arthroplasty (Girdlestone for hip): Salvage option for non-ambulatory patients or when reimplantation is contraindicated.
• Amputation: Last resort for uncontrolled infection with limb/life-threatening sepsis.

Cardiac Device Infections (CIED)

Per AHA/HRS 2017 Expert Consensus on CIED Infections:

• Complete device and lead removal is recommended for all CIED infections (pocket infection + lead/endovascular infection)
• Transvenous lead extraction (TLE) via mechanical or laser sheaths; surgical extraction reserved for failed TLE
• Prolonged bactericidal antibiotics (4–6 weeks for endovascular infection)
• Reimplantation timing: minimum 72 hours after blood cultures clear; contralateral side preferred

Infected Vascular Grafts

Infected aortic or peripheral vascular grafts require complete graft excision (CPT 35907 for aortic) and extra-anatomic bypass (axillary-bifemoral or other route). In situ reconstruction with cryopreserved homograft or antibiotic-soaked synthetic graft is an emerging alternative. Mortality for infected aortic prosthetic grafts remains 15–25% despite treatment per vascular surgery literature.

Ventricular Shunt Malfunction

• Mechanical obstruction: complete shunt revision (CPT 62230) or partial revision (CPT 62225); emergent when associated with elevated ICP
• Shunt infection: externalization of shunt + IV antibiotics × 10–14 days → delayed new shunt placement when CSF cultures clear

Peritoneal Dialysis Catheter Complications

PD peritonitis: intraperitoneal antibiotics (vancomycin + ceftazidime per ISPD 2022 guidelines); catheter removal if refractory (culture-negative at 5 days or non-responding). Mechanical complications (omental wrapping, malposition): repositioning, omentectomy if needed.

🎓 Patient Education / Summary

Patient-facing communication should cover the following key points for those with implanted devices:

Warning Signs to Report Immediately

• Fever above 101°F (38.3°C) — particularly in the first 12 weeks after implantation or years later (hematogenous infection)
• Increasing redness, warmth, swelling, or drainage around the surgical site
• Sudden onset of severe pain at the device site, especially with prior history of well-functioning prosthesis
• For joint replacements: acute inability to bear weight or sudden change in joint stability (possible dislocation)
• For pacemaker/ICD: visible erosion of skin over device pocket; pulsating or tender pocket
• For VP shunts: headache, nausea/vomiting, visual changes, altered consciousness — signs of shunt malfunction/raised ICP

Infection Prevention

• Notify ALL healthcare providers (including dentists, dermatologists, and other surgeons) about any implanted device before procedures
• Carry a device identification card (provided at implantation); MRI safety identification for neurostimulators and pacemakers
• Complete antibiotic courses as prescribed; do not stop early even if feeling better
• Monitor for signs of infection at other body sites (dental, skin, urinary) that could seed the device via bloodstream

Living with an Implanted Device

Most patients with well-functioning implanted devices lead full and active lives. Joint replacements typically last 15–20 years per AAOS joint replacement statistics. Modern pacemakers and ICDs require generator replacement every 7–12 years depending on battery usage. Understanding the specific type of device, manufacturer, and model number is important for medical management and emergency care.

For Documentation Purposes

Physicians and advanced practice providers: complete, specific documentation of device-related complications directly impacts care coordination, reimbursement accuracy, and population health reporting. Use of precise terminology — “periprosthetic joint infection of the right hip due to MRSA,” “mechanical loosening of the left knee prosthesis — aseptic,” or “thrombosis of prosthetic aortic valve, initial encounter” — ensures accurate code assignment, appropriate DRG classification, and correct HCC capture under the Medicare Advantage v28 risk adjustment model.

About this Guide

This Clinical Documentation Guide is published by CCO Academy and is intended for credentialed coding, CDI, and clinical documentation professionals. Content is updated for FY2026 ICD-10-CM (effective October 1, 2025). All code assignments should be verified against the official ICD-10-CM Tabular List, AHA Coding Clinic, and applicable payer-specific policies. This guide does not constitute legal, medical, or compliance advice.

Last reviewed: April 2026 · Next scheduled review: October 2026 (FY2027 update)